| Literature DB >> 31667378 |
Adewumi Oluwasogo Dada1, Folahan Amoo Adekola2, Fehintoluwa Elizabeth Dada3, Adunola Tabitha Adelani-Akande4, Micheal Oluwasesan Bello5,6, Chidiogo Rita Okonkwo1, Adejumoke Abosede Inyinbor1, Abimbola Peter Oluyori1, Adeniyi Olayanju7, Kolawole Oluseyi Ajanaku8, Charles Oluwaseun Adetunji9.
Abstract
Single pot green synthesis of silver nanoparticles (AgNPs) was successfully carried out using medicinal plant extract of Acalypha wilkesiana via bottom-up approach. Five imperative operational parameters (pH, contact time, concentration, volume ratio and temperature) pivotal to the synthesis of silver nanoparticles were investigated. The study showed pH 9, 90 min contact time, 0.001 M Ag+ concentration, volume ratio 1:9 (extract: Ag+ solution), and temperature between 90 - 100 °C were important for the synthesis of Acalypha wilkesiana silver nanoparticles (AW-AgNPs). Phytochemical screening confirmed the presence of saponins, flavonoids, phenols and triterpenes for A. wilkesiana. These phytomolecules served as both capping and stabilizing agent in the green synthesis of silver nanoparticles. AW-AgNPs was characterized by UV-Vis Spectroscopy, Fourier Transform Infrared (FTIR) Spectroscopy and Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM) and Energy Dispersive X-ray (EDX). The surface Plasmon resonance (SPR) was observed at 450 nm which is a characteristic absorbance region of AW-AgNPs formation as a result of the collective oscillation of free electron of silver nanoparticles. FTIR Spectroscopy confirmed the presence of functional groups responsible for bioreduction of Ag+. SEM and TEM results confirmed a well dispersed AW-AgNPs of spherical shape. EDX shows the elemental distribution and confirmed AgNPs with a characteristic intense peak at 3.0 keV. AW-AgNPs showed significant inhibition against selected Gram negative and Gram positive prevailing bacteria. AW-AgNPs can therefore be recommended as potential antimicrobial and therapeutic agent against multidrug resistant pathogens.Entities:
Keywords: Acalypha wilkesia; Analytical chemistry; Antimicrobial studies; Biotechnology; Environmental health; Materials chemistry; Nanomaterials; Operational parameters; Organic chemistry; Pharmaceutical chemistry; Pharmaceutical science; Pharmacology; Physical chemistry; Silver nanoparticles
Year: 2019 PMID: 31667378 PMCID: PMC6812196 DOI: 10.1016/j.heliyon.2019.e02517
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Fig. 1Typical Acalypha wilkesiana plant (snapped in Landmark University environment).
Phytochemical screening test results on Acalypha wilkesiana extracts.
| S/N | Phytochemical Screening | |
|---|---|---|
| 1 | Test for Phenols (FeCl3) | + |
| 2 | Test for Triterpenes | ++ |
| 3 | Test for Saponins (Froth's test) | + |
| 4 | Test for Steroids (Salkowski's test) | - |
| 5 | Test for Alkaloids (Mayer's test) | - |
| 6 | Test for Flavonoids | |
| (a) Lead Acetate test | + | |
| (b) Alkali test (NaOH) | + |
Table Key: - = Absent, + = Present, ++ = Present in abundance.
Fig. 2UV-Vis Spectra of AW-AgNPs with SPR peak at 460nm.
FTIR Vibration bands of Raw AW & AW-AgNPs.
| Functional Group | Frequency/Vibrational Bands of Raw AW (cm−1) | Frequency/Vibrational Bands of AW-AgNPs (cm−1) |
|---|---|---|
| -OH- | 3566 | 3477 |
| -C-H- | 2068 | 2059 |
| -C=C- | 1641 | 1641 |
| (- CH3-) | 1384 | 1349 |
| (- C–N-) | 694 | 772 |
Fig. 3FTIR spectra of (A) Extract of AW and (B) Synthesized AW-AgNPs.
Fig. 4SEM micrograph of AW-AgNPs.
Fig. 5TEM micrograph of AW-AgNPs.
Fig. 6EDX spectrum of AgNPs.
Fig. 7(a–e): Experimental optimization of various operational parameters on effects of: (a) concentration (b) contact time (c) volume ratio (d) change in pH (e) temperature.
Antimicrobial result for Plates 1 & 2.
| Samples | ||||||
|---|---|---|---|---|---|---|
| Plate 1 | Plate 2 | MD (mm) | Plate 1 | Plate 2 | MD (mm) | |
| 0 | 0 | 0 | 0 | 0 | 0 | |
| 20 | 18 | 19 | 18 | 16 | 17 | |
| Positive Control | 30 | 27 | 29 | 32 | 26 | 29 |
| Negative Control | 0 | 0 | 0 | 0 | 0 | 0 |
Key: MD = Mean Diameter (mm).
Fig. 8Antimicrobial activity of AW-AgNPs against Staphylococcus aureus and Escherichia coli.
Fig. 9Plates showing the antimicrobial activities of biosynthesized AW-AgNPs against Staphylococcus aureus (plate 1) and Escherichia coli (Plate 2).